_edited.png)
LAIT - IMMUNOTHERAPY LABORATORY

September 2nd and 3rd, 2025
Porto Alegre/RS
The II National Immunotherapy Symposium is a unique event that brings together professionals from different areas of health to discuss the latest trends and advances in immunotherapy with a focus on oncology and precision medicine.
HOT TOPICS
-
Development of novel monoclonal antibodies
-
Precision oncology with national technology
-
Identification of new therapeutic targets
-
Clinical studies with CAR-T cells
Venue
Federal University of Health Sciences of Porto Alegre (UFCSPA)
Sarmento Leite, 245, CEP: 90050-170
Building 2, third floor, Moacyr Scliar Theater

Program
September 2nd, 2025:
-
08:30 - Registration
-
09:00-10:00 - Course
-
10:00-10:30 - Break
-
10:30-11:30 - Course: Gabriel Pozo (UFCSPA) - Desvendando nichos celulares através da transcriptoma espacial
-
11:30-12:30 - Course BD: Família BD FACSDiscover – Citometria espectral e imagem em tempo real | Guilherme Evangelista
-
12:45-13:45 - Satellite Symposium
-
14:00-14:15 - Official Opening
-
14:15-16:00 - Round Table 1: Antibodies
-
Andre Vale (UFRJ) “Comprehensive analysis of the human SARS-CoV-2 memory B cell repertoire in low-resource settings”
-
Iaralice Medeiros (Fiocruz RJ) “Development of Biosimilars in Brazil: The Path to Comparability and its Challenges”
-
Cristina Bonorino (UFCSPA) “Characterization of novel anti-PD-L1 antibodies isolated from the repertoire of lung cancer patients”
-
15:45-16:45 - BD Lab visit in LAIT (participants will be drawn)
-
-
-
16:00-16:30 - Break
-
16:30-18:30 - Round Table 2: CAR-T
-
Martin Bonamino (INCA) "Tropical CAR Cells: A Rio-Based Perspective on CAR-T Cell Therapy"
-
Giancarlo Fatobene (HC- FM USP) “CAR T-Cell Therapy Initiatives for Hematological Tumors in Brazil”
-
Lucila Kerbauy (Einstein) “CAR-T Cell and CAR-NK Cell Treatment for Hematological Malignancies”
-
Andreia Maranhão (UNB) "Design of New CARs for the Treatment of Hematological Oncologies"
-
-
18:30-19:30 - Happy Poster - Selected Poster
September 3nd, 2025:
-
08:00 - Registration
-
08:30-09:00 - Course Illumina: Revolutionizing Single-Cell Sequencing with Illumina’s New Integrated Solution
-
09:00-10:30 - Round Table 3: Tumors in Women
-
Andreia Melo (INCA) "Immunotherapy in Gynecological Tumors"
-
Mariana Boroni (INCA) "Mapping Chemotherapy Resistance in Ovarian Cancer with Spatial Transcriptomics"
-
Rodrigo Nalio (IDOR and FMUSP): "CAR-Macrophages as an Alternative in the Fight against Breast Cancer"
-
-
10:30-11:00 - Break
-
11:00-13:00 - Round Table 4: Immunology in the Clinic
-
Stephan Soder (ISCMPA and HMV) "Genomic and Transcriptomic Analysis of a Lung Cancer Cohort"
-
Fabio Franke (Unimed and CACON) "Clinical Research in Immunotherapy at Grupo Oncoclínicas"
-
Danielli Oliveira (INCA) "REDOME: Voluntary Bone Marrow Donor Registries and Advanced Cellular Therapies"
-
Elizandra Braganhol (UFCSPA) "Purineric Signaling as an Innovative Target for Oncology Immunotherapy"
-
-
13:00-14:00 - Cytiva Satellite Symposium
-
14:00-16:00 - Round Table 5: Innovative Strategies
-
Mariano Zallis (Instituto Oncoclínicas and UFRJ) "CIPOT: Innovation and Integration in Translational Oncology Research"
-
Leandro Coli (USP-RP) O Multiverso do Câncer: o papel da multiômica para entender a complexidade do câncer
-
Leda Castilho (UFRJ) "Development of Technologies for Recombinant Vaccine Production"
- Carol Albuquerque (PUCRS) "Immunotherapy in uveal melanoma"
-
-
16:00-16:30 - Closing Conference: João Viola (INCA) "Cancer and Inflammation: Obesity as a Risk"
-
16:30-17:00 - Break and visit to the exhibition and poster area
-
17:00-18:00 - ABRIT Assembly
-
18:00 - Closing

Confirmed speakers
Experimental research
-
Adriana Bonomo (FIOCRUZ/IOC)
-
Andre Vale (UFRJ)
-
Andreia Maranhão (UNB)
-
Cristina Bonorino (UFCSPA)
-
Elizandra Braganhol (UFCSPA)
-
João Viola (ICB USP)
-
José Alexandre Barbuto (USP)
-
Kelly Magalhães (UNB)
-
Kenneth Gollob (EINSTEIN)
-
Larissa Cunha (FMUSPRP)
-
Leda Castilho (UFRJ)
-
Mariana Boroni (INCA)
-
Martin Bonamino (INCA)
-
Rodrigo Nalio (IDOR e FMUSP)
Clinical research
-
Andreia Mello (INCA)
-
Caroline Albuquerque (CPO -PUCRS)
-
Fabio Franke (Unimed e CACON)
-
Leandro Machado Colli (USP-FMRP)
-
Lucila Kerbauy (Einstein)
-
Mariano Zalllis (Instituto Oncoclinicas e UFRJ)
-
Rafael Vargas (ISCMPA)
-
Stephan Soder (ISCMPA e HMV)
Submission Rules
Submission deadline: 20.08.2025
Results announcement: 27.08.2025
RESPOND TO GOOGLE FORM, LINK BELLOW
Submission rules
-
Presentations could be in Portuguese or English;
-
Submit references separately from the abstract;
-
Abstract in accordance with ABNT;
-
References in the abstract must be restricted to a minimum, only numbers;
-
Abstracts must not exceed two thousand (2,000) characters, including spaces;
-
Abstract titles must not exceed 255 characters, including spaces;
-
The names, e-mails, CPF (only for Brazilians), passport numbers and affiliations of all authors must be included in the abstract submission form;
-
Abbreviations must be defined when they are mentioned for the first time in the abstract;
-
Abstracts must not contain tables, graphs or images.
Any questions, please send an email: lab.imunoterapia@gmail.com
Please name the email subject as:
"II National Immunotherapy Symposium - Abstract Subimission"
%20(2).jpg)
Evaluation Criteria
-
Presentations could be in Portuguese or English;
-
All approved abstracts must be accompanied by the respective presentation in poster format. The poster must be presented, obligatorily, by the author responsible for submitting the abstract (PRESENTER), at the time and place established by the event organizers;
-
The presentations will be evaluated by an independent committee, based on the following criteria:
-
Relevance of the topic
-
Originality and innovation
-
Clarity and objectivity in the presentation
-
Methodological and scientific quality of the research
-
Conclusions and contributions to the field of knowledge
-

Support






organized by
.png)